A Retrospective Analytical Approach to Treatment Outcome of 40 Anemias
Journal Title: Medical Journal of Clinical Trials & Case Studies - Year 2020, Vol 4, Issue 1
Abstract
Objective: Anemia is clinical common event. There are many types of anemias, which included stem cell problems, vitamin deficiency, chronic diseases and drug antibody-induced immune hemolytic anemia. In this study, a retrospective purpose was investigated to assess the clinical efficacy of treatment and their outcome. Methods: 40 patients with different types of anemias were presented during 1989-2019. The therapeutical design among those patients with anemias was setted to the various regimen according to diseases diagnoses. Results and conclusion: 23 patients achieved cure or complete remission (CR), with the exception of refractory cancers and uremic anemia. Iron supplement was provided in 5 iron deficiency anemia. One megaloblastic anemia produced an excellent response following the supplement of vitamin B12 and folic acid. 2 aplastic anemia obtained complete remission (CR) with the integrated protocol of methyltestosterone,adenine, leucogen,and levamisol. Steroid hormone(e.g. prednisone) mixed traditional medicine were occasionally promising benefit in a nephrotic syndrome and renal insufficiency. Among 2 cases with drug-induced immune hemolytic anemia (DIIHA), laboratory studies one patient’s serum contained paracetamol-dependent antibody that in the presence of paracetamol, agglutinated in vitro with “O” red cells with or without complement. Drug antibody titer was 1:4 positive. The immune hemolysis was mediated via both immune complex and drug-adsorption, while another herba origanum vulgare- induced hemolysis secondary to drug adsorption only. In addition, as to anemia caused by malignant tumours, the molecular genetic regulation of retinoic acid in acute promyelocytic leukemia (APL) has been further illustrated (see figure in full text). Therefore, to strengthen the active prevention and/or early interceptive treatment of anemia is our care.
Authors and Affiliations
Zhu G*
Keywords
Related Articles
- EP ID EP756015
- DOI 10.23880/mjccs-16000254
- Views 33
- Downloads 0
The Human Chromosome 21 Gene TIAM-1 Over-Expressed in Down Syndrome Could be a Valuable Predictive Biomarker and a Potential Therapeutic Target for Treatment of Multiple Clinical Tumors and Cancers
Down syndrome, the triplication of human chromosome 21, is the most frequent genetic disorder associated to numerous diseases with hard impact on public health. Remarkably, the over-expression of most genes on this chrom...
Role of Plastic Periodontal Therapy in Clinical Management of Orthodontically Treated Vertical Maxillary Excess
Introduction: The most challenging task for an orthodontist is to achieve harmonious smile, especially in ‘‘gummy smile' or (vertical maxillary excess) cases. These kinds of cases are treated with either intrusion or ort...
Brief Analysis about the Smoking Economic Benefits
Background: Smoking is given by the tobacco consumption. Thus all smoking economic benefits are based on this fact. Some economic sectors are benefited from the smoking economic impact over the health services demand. Th...
Non-Specific Immune Modulation Response by Use of Aboriginal Potent Herbal Combination in Diabetic Urban Population
World, a globally experiencing rapid socioeconomic progress and urbanization, carries a considerable share of the global diabetes burden. In the present study, powdered dodecyl sulphate of ‘poly-herbal formulation’ was...
New Therapies for the Treatment of Spastic Cerebral Palsy
Background: Cerebral palsy is a heterogeneous condition associated with a non-progressive lesion, but permanent disorder of movement with limited mobility. It is generally associated with gross motor developmental delay...